These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 294834)
1. Detection of "dialyzable transfer factor" in vitro: structural and chemical characterization of the activity specific for tuberculin. Wilson GB; Fudenberg HH; Paddock GV Ann N Y Acad Sci; 1979; 332():579-90. PubMed ID: 294834 [No Abstract] [Full Text] [Related]
2. Effects of dialyzable leukocyte extracts (DLE) with transfer factor activity on leukocyte migration in vitro. IV. Two distinct effects of DLE on leukocyte migration can be produced by prostaglandins. Wilson GB; Fudenberg HH; Jonsson HT; Smith CL Clin Immunol Immunopathol; 1980 May; 16(1):90-102. PubMed ID: 7379353 [No Abstract] [Full Text] [Related]
4. Characterization of Tx, an active subfraction of human dialyzable transfer factor. I. Identification of the major component in TFg, a precursor of Tx, as hypoxanthine. Wilson GB; Welch TM; Knapp DR; Horsmanheimo A; Fudenberg HH Clin Immunol Immunopathol; 1977 Nov; 8(3):551-68. PubMed ID: 912950 [No Abstract] [Full Text] [Related]
5. Transfer factor (TFd). Part III. In vitro effects on the leucocyte migration inhibition. Markowicz S; Plucińska M; Drela N; Grubek-Jaworska H; Rzucidło L Mater Med Pol; 1981; 13(2):104-7. PubMed ID: 7345252 [No Abstract] [Full Text] [Related]
6. The effect of transfer factor on the in vitro migration of tuberculin stimulated white cells from sarcoid and normal subjects. Park JR; De Bats A; Rhodes EL Br J Dermatol; 1975 May; 92(5):535-40. PubMed ID: 1174466 [TBL] [Abstract][Full Text] [Related]
8. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition. Wilson GB; Fudenberg HH; Bahm VJ Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397 [No Abstract] [Full Text] [Related]
9. Bovine 'transfer factor': an oligoribonucleopeptide which initiates antigen-specific lymphocytes responsiveness. Wilson GB; Paddock GV; Fudenberg HH Thymus; 1982; 4(6):335-50. PubMed ID: 6191411 [TBL] [Abstract][Full Text] [Related]
10. Clinical study of a patient with lupus vulgaris before and after injection of dialyzable transfer factor. Horsmanheimo M; Krohn K; Virolainen M J Invest Dermatol; 1977 Jan; 68(1):10-5. PubMed ID: 318672 [TBL] [Abstract][Full Text] [Related]
11. Phytohaemagglutinin and transfer factor in the leucocyte migration inhibition test in patients with sarcoidosis. Morison WL Thorax; 1976 Feb; 31(1):87-90. PubMed ID: 943868 [TBL] [Abstract][Full Text] [Related]
12. [The current state of the problem of the nature and mechanism of action of "transfer factor"]. Sakharov PP; Kudrina GP Zh Mikrobiol Epidemiol Immunobiol; 1976 May; (5):10-6. PubMed ID: 821270 [No Abstract] [Full Text] [Related]
13. Augmentation of 3H-thymidine incorporation by human lymphocytes in the presence of antigen and fractions of dialyzable transfer factor: a nonspecific phenomenon. Littman BH; Hirschman EM; David JR Cell Immunol; 1977 Jan; 28(1):158-66. PubMed ID: 64313 [No Abstract] [Full Text] [Related]
14. Inhibition of DNA synthesis in lymphocytes by dialyzable components of human leukocyte extracts. Saito K; Tamaki N; Foster LA; Brennessel B; Gottlieb AA Cell Immunol; 1977 Jun; 31(2):311-20. PubMed ID: 301440 [No Abstract] [Full Text] [Related]
15. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides. Wilson GB; Paddock GV; Fudenberg HH Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106 [TBL] [Abstract][Full Text] [Related]
16. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part III. Biochemical characterization. (third of three parts). Ablin RJ Allergol Immunopathol (Madr); 1980; 8(3):203-12. PubMed ID: 7405767 [No Abstract] [Full Text] [Related]
17. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg]. Hashimoto Y; Sekiguchi S Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264 [TBL] [Abstract][Full Text] [Related]
18. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. 1. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration. Wilson GB; Fudenberg HH; Horsmanheimo M J Lab Clin Med; 1979 May; 93(5):800-18. PubMed ID: 429876 [TBL] [Abstract][Full Text] [Related]
19. [The preparation and characterization of transfer factor (author's transl)]. Schröder I; Werner H; Lorenz U; Köhler H; Jenssen HL Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):365-71. PubMed ID: 126568 [TBL] [Abstract][Full Text] [Related]
20. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects. Wilson GB; Fudenberg HH J Lab Clin Med; 1979 May; 93(5):819-37. PubMed ID: 429877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]